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Flavin nucleotides act as electron shuttles mediating reduction
of the [2Fe-2S] clusters in mitochondrial outer membrane protein
mitoNEET
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Aaron P. Landry1, Yiming Wang1, Zishuo Cheng, Robert B. Crochet, Yong-Hwan Lee, and
Huangen Ding*
Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA

Abstract

Author Manuscript

MitoNEET, a primary target of type II diabetes drug pioglitazone, has an essential role in
regulating energy metabolism, iron homeostasis, and production of reactive oxygen species in
mitochondria. Structurally, mitoNEET is anchored to the mitochondrial outer membrane via its Nterminal transmembrane α-helix. The C-terminal cytosolic domain of mitoNEET hosts a redox
active [2Fe-2S] cluster via three cysteine and one histidine residues. Here we report that the
reduced flavin nucleotides can rapidly reduce the mitoNEET [2Fe-2S] clusters under anaerobic or
aerobic conditions. In the presence of NADH and flavin reductase, about 1 molecule of flavin
nucleotide is sufficient to reduce 100 molecules of the mitoNEET [2Fe-2S] clusters in 4 minutes
under aerobic conditions. The electron paramagnetic resonance (EPR) measurements show that
flavin mononucleotide (FMN), but not flavin adenine dinucleotide (FAD), has a specific
interaction with mitoNEET. Molecular docking models further reveal that flavin mononucleotide
binds mitoNEET at the region between the N-terminal transmembrane α-helix and the [2Fe-2S]
cluster binding domain. The closest distance between the [2Fe-2S] cluster and the bound flavin
mononucleotide in mitoNEET is about 10 Å, which may facilitate rapid electron transfer from the
reduced flavin nucleotide to the [2Fe-2S] cluster in mitoNEET. The results suggest that flavin
nucleotides may act as electron shuttles to reduce the mitoNEET [2Fe-2S] clusters and regulate
mitochondrial functions in human cells.
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INTRODUCTION
Human mitochondrial outer membrane protein mitoNEET was initially identified as a target
of type II diabetes drug pioglitazone [1]. While deletion of mitoNEET in mice significantly
decreases oxidative phosphorylation activity in mitochondria [2], increased expression of
mitoNEET in adipocytes enhances lipid uptake and storage of the cells and inhibits
mitochondrial iron transport into matrix [3]. In beta cells, increased expression of
mitoNEET leads to hyperglycemia and glucose intolerance [4]. Misregulation of mitoNEET
expression has also been attributed to the development of neurodegenerative disease [5, 6]
and cardiovascular disease [7], breast cancer proliferation [8–10], browning of white adipose
tissue [11], among other pathological conditions [12]. It has thus been proposed that
mitoNEET is a key regulator for energy metabolism, iron homeostasis, and production of
reactive oxygen species in mitochondria [13].
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MitoNEET is a homodimer with each monomer containing an N-terminal transmembrane αhelix (residues 14 to 32) anchored to the mitochondrial outer membrane [1]. The C-terminal
cytosolic domain (residues 33–108) of mitoNEET hosts a redox active [2Fe-2S] cluster via a
unique ligand arrangement of three cysteine and one histidine residues [14–16]. As
mitochondria are the primary sites for iron-sulfur cluster biogenesis [17], several studies
have suggested that mitoNEET may mediate transfer of iron-sulfur clusters assembled in
mitochondria to target proteins in cytoplasm [18–21]. However, the cluster transfer occurs
only when the mitoNEET [2Fe-2S] clusters are in oxidized state [18, 21], indicating the
transfer process is controlled by the redox state of the [2Fe-2S] clusters [22, 23].
Alternatively, mitoNEET may directly regulate mitochondrial functions via the redox
transition of the [2Fe-2S] clusters [4, 22–24], as mitoNEET forms complexes with multiple
mitochondrial proteins including the Parkinson's disease associated protein Parkin [4, 25,
26] and mitochondrial outer membrane import complex protein 1 (MTX1) [27].
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Intracellular redox co-enzymes including nicotinamide adenine dinucleotide (NAD+),
nicotinamide adenine dinucleotide phosphate (NADP+), flavin mononucleotide (FMN), and
flavin adenine dinucleotide (FAD) are considered as natural biomarkers of metabolic
activities and mitochondrial anomalies [28]. If mitoNEET is a key regulator of energy
metabolism in mitochondria [13], it is expected that mitoNEET will have direct interactions
with the redox co-enzymes in cells. Indeed, previous studies have shown that mitoNEET is
able to bind NADP(H) (but not NAD(H)) [29], and that binding of NADPH in mitoNEET
destabilizes the [2Fe-2S] clusters [29] and inhibits the [2Fe-2S] cluster transfer from
mitoNEET to target proteins [30]. However, the interaction between mitoNEET and
NADP(H) is fairly weak (with a dissociation constant of about 2.0 mM) [29]. Furthermore,
both NADPH and NADH fail to reduce the mitoNEET [2Fe-2S] clusters under anaerobic or
aerobic conditions [22, 23, 30]. Here, we report that the reduced flavin nucleotides can
rapidly reduce the mitoNEET [2Fe-2S] clusters under anaerobic or aerobic conditions. The
electron paramagnetic resonance (EPR) measurements show that flavin mononucleotide, but
not flavin adenine dinucleotide, has a specific interaction with mitoNEET. Furthermore,
molecular docking models reveal that flavin mononucleotide binds mitoNEET at the region
between the N-terminal transmembrane α-helix and the [2Fe-2S] cluster binding domain.
Such an arrangement may facilitate rapid electron transfer from the reduced flavin
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nucleotide to the [2Fe-2S] clusters in mitoNEET. Our results suggest that mitoNEET may
sense redox state of intracellular redox co-enzymes to modulate energy metabolism, iron
homeostasis, and production of reactive oxygen species in mitochondria.

MATERIALS AND METHODS
1. Protein preparation

Author Manuscript

Escherichia coli flavin reductase (Fre) was prepared using an E. coli strain hosting an
expression plasmid encoding Fre from the ASKA library [31]. Human mitochondrial outer
membrane protein mitoNEET33–108 (containing residues 33–108) was purified as described
in [23]. MitoNEET with deletion of the segment between Arg-33 and Ile-45 was prepared
using the site-directed mutagenesis (Agilent co.), and confirmed by direct sequencing. The
purity of purified proteins was greater than 95% as judged by electrophoresis analysis on a
15% polyacrylamide gel containing SDS followed by staining with Coomassie Blue. The
protein concentrations of mitoNEET and E. coli Fre were measured at 280 nm using an
extinction coefficient of 8.6 and 26.4 mM−1cm−1, respectively. The UV-visible absorption
spectra were measured in a Beckman DU640 UV-visible absorption spectrometer equipped
with a temperature controller.
2. Iron and sulfide content analyses
The iron content of protein samples was determined using ferroZine [32] as described
previously [33]. The sulfide contents of protein samples was determined according to the
Siegel’s method [34]. Purified E. coli endonuclease III containing a stable [4Fe-4S] cluster
[35] was used as a standard for the iron and sulfide content analyses in protein samples.
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3. EPR measurements
The X-band Electron Paramagnetic Resonance (EPR) spectra were recorded using a Bruker
model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow
cryostat. Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power,
10.0 mW; modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 30
K; receiver gain, 2×105.
4. Chemicals
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NADH, NADPH, Isopropyl-β-D-1-thiogalactopyranoside, kanamycin, and ampicillin were
purchased from Research Product International co. FMN, FAD, and other chemicals were
purchased from Sigma co. Extinction coefficients of 6.2 mM−1cm−1 at 340 nm, 12.5
mM−1cm−1 at 445 nm, and 11.3 mM−1cm−1 at 450 nm were used for NADH/NADPH, FMN
and FAD, respectively [28].
5. Molecular docking
The protocol for AutoDockVina-based molecular docking is a modification from Garret M.
Morris’ (The Scripps Research Institute, La Jolla, CA) [36]. The validity of this protocol
was established during other studies [37]. Partial conformational flexibility was allowed to
the residues in direct contacts with targets. Docking is made based on binding energy
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calculation using Lamarckian Genetic Algorithm implemented in AutoDock3 [36]. The
detailed docking parameters per molecule are: the energy evaluations number = 1750000,
the population size = 150, the trial number = 20, and the positional rms tolerance = 2.0 Å.

RESULTS
1. Reduced flavin nucleotides rapidly reduce the mitoNEET [2Fe-2S] clusters under aerobic
conditions

Author Manuscript

Unlike NADPH or NADH, reduced flavin nucleotides (FMNH2 and FADH2) are not stable
under aerobic conditions and not commercially available. To prepare FMNH2 or FADH2, we
purified Escherichia coli flavin reductase (Fre) from an E. coli ASKA library strain [31].
Figure 1A shows that purified E. coli Fre does not have any prosthetic groups as reported in
[38], and is fully active to reduce FMN/FAD to FMNH2/FADH2 using NADH as electron
donor [39].
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To monitor the redox state of the mitoNEET [2Fe-2S] clusters, we used the UV-visible
absorption spectroscopy. Purified human mitoNEET has two major absorption peaks at 458
nm and 540 nm, indicative of the oxidized [2Fe-2S] clusters in the protein [18, 22] (Figure
1B, spectrum 1). When mitoNEET is incubated with a catalytic amount of purified E. coli
Fre (Figure 1B, spectrum 2) or Fre and NADH (Figure 1B, spectrum 3) under aerobic
conditions, the mitoNEET [2Fe-2S] clusters remain oxidized. However, when mitoNEET is
incubated with E. coli Fre, NADH and FMN under aerobic conditions, the mitoNEET
[2Fe-2S] clusters are fully reduced, as indicated by a new absorption peak at 420 nm (Figure
1B, spectrum 4). Thus, while Fre or Fre/NADH fails to reduce the mitoNEET [2Fe-2S]
clusters, FMN reduced by Fre and NADH can fully reduce the mitoNEET [2Fe-2S] clusters
under aerobic conditions. Similar results are observed when FMN is replaced with FAD in
the incubation solutions (data not shown).
In parallel experiments, we used the electron paramagnetic resonance (EPR) spectroscopy to
evaluate the redox state of the mitoNEET [2Fe-2S] clusters in the above reaction solutions.
While the oxidized mitoNEET [2Fe-2S] clusters are EPR silent, the reduced mitoNEET
[2Fe-2S] clusters have a distinct EPR signal at g = 1.94 [23, 40]. Figure 1C shows that the
mitoNEET [2Fe-2S] clusters are reduced only after mitoNEET is incubated with Fre, NADH
and FMN or FAD (not shown). Thus, the mitoNEET [2Fe-2S] clusters can be efficiently
reduced by the reduced flavin nucleotides under aerobic conditions.
2. Reversible reduction of the mitoNEET [2Fe-2S] clusters under aerobic conditions

Author Manuscript

Since the redox midpoint potential (Em7) of the mitoNEET [2Fe-2S] clusters is about 0 mV
[24], the reduced [2Fe-2S] clusters in mitoNEET could be readily oxidized by oxygen under
aerobic conditions. To test this idea, mitoNEET is pre-incubated with FMN and a limited
amount of NADH under anaerobic conditions, followed by addition of a catalytic amount of
flavin reductase (Fre). As shown in Figure 2A, addition of Fre leads to a rapid reduction of
the mitoNEET [2Fe-2S] clusters under anaerobic conditions. When the reaction solution is
exposed to air, the reduced mitoNEET [2Fe-2S] clusters are quickly oxidized (Figure 2B,
spectrum 3). However, when additional NADH is added to the reaction solution, the
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mitoNEET [2Fe-2S] clusters are re-reduced under aerobic conditions (Figure 2A). The
results suggest that under aerobic conditions, a continuous supply of NADH is required for
maintaining the reduced state of the mitoNEET [2Fe-2S] clusters in the presence of flavin
reductase and flavin nucleotide. Thus, the redox state of the mitoNEET [2Fe-2S] clusters
may be controlled by the reduced redox co-enzymes in cells under aerobic conditions.
3. Flavin nucleotides act as electron shuttles mediating reduction of the mitoNEET
[2Fe-2S] clusters
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Flavin reductase reduces flavin nucleotides using NADH as electron donor without tightly
binding its substrates or products [39]. We assume that flavin nucleotides reduced by flavin
reductase will diffuse from the enzyme to reduce the [2Fe-2S] clusters in mitoNEET. To
explore this idea, mitoNEET (containing 10 µM [2Fe-2S] cluster) is pre-incubated with Fre
(1 µM) and various concentrations of FMN under aerobic conditions. The reduction of the
mitoNEET [2Fe-2S] clusters in solutions is initiated by adding NADH (100 µM). Figure 3A
shows that without FMN, there is no reduction of the mitoNEET [2Fe-2S] clusters. As the
concentration of FMN is increased from 0 to 0.2 µM in the incubation solution (Figure 3B–
F), the mitoNEET [2Fe-2S] clusters are quickly reduced under aerobic conditions.
The amounts of the reduced mitoNEET [2Fe-2S] clusters are measured after 4 min
incubation with Fre, NADH and various concentrations of FMN or FAD, and plotted as a
function of the flavin nucleotide concentrations. Figure 4A shows that about 0.1 µM FMN is
sufficient to fully reduce 10 µM mitoNEET [2Fe-2S] clusters after 4 min incubation. Similar
results are observed when FMN is replaced with FAD in the reaction solutions (Figure 4B).
These results suggest that flavin nucleotides may act as electron shuttles to efficiently reduce
the mitoNEET [2Fe-2S] clusters under aerobic conditions.
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4. EPR evidence for flavin mononucleotide binding in mitoNEET
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As a catalytic amount of flavin nucleotides is sufficient for reduction of the mitoNEET
[2Fe-2S] clusters (Figure 4), we postulate that mitoNEET may have specific interactions
with flavin nucleotides. In the experiments, mitoNEET is pre-incubated with 10-fold excess
of NADP+, NAD+, FAD, or FMN in buffer containing 500 mM NaCl and 20 mM Tris (pH
8.0) for 30 min under aerobic conditions. The samples are then reduced with freshly
prepared sodium dithionite to fully reduce the redox co-enzyme and the mitoNEET [2Fe-2S]
clusters for the EPR measurements, as only the reduced mitoNEET [2Fe-2S] clusters are
paramagnetic and EPR visible [23, 40]. Any change of the EPR spectrum would reflect
potential interactions between the reduced co-enzyme and the reduced [2Fe-2S] clusters in
mitoNEET. Figure 5A shows that NADPH and NADH has very little or no effects on the
EPR spectrum of the reduced mitoNEET [2Fe-2S] clusters (spectra 2–3), consistent with the
idea that NADPH and NADH have a weak interaction with mitoNEET [29]. In contrast,
incubation with FMNH2 produces a new EPR signal at g = 1.85 (spectrum 4), suggesting
that FMNH2 may have a specific interaction with the reduced [2Fe-2S] clusters in
mitoNEET. Interestingly, incubation with FADH2 does not have any significant effects on
the EPR spectrum of the reduced mitoNEET [2Fe-2S] clusters (spectrum 5). Perhaps, the
AMP moiety in FAD may obstruct the interaction between FADH2 and the [2Fe-2S] clusters
in mitoNEET.
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MitoNEET is then incubated with increasing concentrations of FMN under aerobic
conditions, followed by reduction with freshly prepared sodium dithionite. Figure 5B shows
that as the concentration of FMNH2 increases from 0 to 200 µM, the amplitude of the EPR
signal at g = 1.85 gradually increases with concomitant decrease of the EPR signal at g =
1.94. Integration of the new EPR signal at g = 1.85 shows when 10 µM mitoNEET [2Fe-2S]
clusters are incubated with 200 µM FMNH2, about 4 µM mitoNEET [2Fe-2S] clusters are
converted to the ones with the EPR signal at g = 1.85. The relatively weak interaction could
be due to the fact that both FMN and the [2Fe-2S] clusters in mitoNEET are in reduced
state. However, attempts to isolate the mitoNEET-FMN complex from the incubation
solutions were not successful. It appears that mitoNEET does not form a stable complex
with FMN, similar as flavin reductase [38]. Nevertheless, the new EPR signal at g = 1.85 of
the reduced mitoNEET [2Fe-2S] clusters at high concentrations of FMNH2 clearly suggests
that mitoNEET has a specific interaction with FMN.
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5. Molecular docking for the flavin mononucleotide binding in mitoNEET

Author Manuscript

To further explore the FMN binding in mitoNEET, we have used molecular docking
approach. Our protocol for AutoDockVina-based Virtual Screening [37] is a modification
from Garret M. Morris’ (The Scripps Research Institute, La Jolla, CA) [36]. The best
docking models for the FMN binding in mitoNEET are shown in Figure 6A. For clarity, only
one monomer in the mitoNEET dimer is shown with the bound FMN molecule. Each
conformation of FMN in mitoNEET represents one docking model. In all docking models
obtained, FMN always binds mitoNEET at the region between the transmembrane α-helix
domain (not shown in Figure 6A) and the [2Fe-2S] cluster domain. The shortest distance
between the [2Fe-2S] cluster and the bound FMN in mitoNEET is about 10 Å. A close
examination of the FMN binding site in mitoNEET shows that His-39 and Lys-42 from
chain 1 form electrostatic interactions with the phosphate group of FMN, while Ile-45 from
chain 1 and Met-44 from chain 2 form hydrophobic interactions with the isoalloxazine group
of FMN (Figure 6B).
To test potential role of the region between Arg-33 and Ile-45 of mitoNEET in binding
FMN, we have constructed a mitoNEET mutant in which the residues between Arg-33 and
Ile-45 are in-frame deleted. Deletion of the region between Arg-33 and Ile-45 has only a
minor effect on the UV-visible absorption spectrum of the [2Fe-2S] clusters in the protein
(Figure 7A). However, the deletion largely abolishes the specific interaction between
FMNH2 and the reduced [2Fe-2S] clusters in mitoNEET (Figure 7B), suggesting that the
region between Arg-33 and Ile-45 is at least partially responsible for the FMN binding in
mitoNEET.
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DISCUSSION
The [2Fe-2S] clusters in mitochondrial outer membrane protein mitoNEET are redox active
with a redox midpoint potential (Em7) of 0 mV [21, 24]. However, cellular components
responsible for reducing the mitoNEET [2Fe-2S] clusters are not fully understood. In
previous studies, we reported that the mitoNEET [2Fe-2S] clusters can be reduced by
biological thiols [22] or human glutathione reductase [23]. However, reduction of the
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mitoNEET [2Fe-2S] clusters mediated by biological thiols [22] or human glutathione
reductase [23] is slow, and must be carried out under anaerobic conditions [22, 23]. Here, we
find that the reduced flavin nucleotides reduced by flavin reductase and NADH can rapidly
reduce the mitoNEET [2Fe-2S] clusters under aerobic conditions (Figure 1). Flavins are
ubiquitous redox co-enzymes in cells [41]. While flavin contents vary in different cell lines,
riboflavin (3.1–5.7 amol/cell) and FAD (12–26 amol/cell) are found to be predominant
flavins with a relatively lower content of FMN (2.7–3.4 atom/cell) in various cell lines [42].
Although riboflavin is considered the precursor of flavin nucleotides [41], we found that the
reduced riboflavin, like the reduced FMN and FAD, can also rapidly reduce the mitoNEET
[2Fe-2S] clusters under aerobic conditions (data not shown). In this context, we propose that
flavin and flavin nucleotides may act as electron shuttles to mediate reduction of the
mitoNEET [2Fe-2S] clusters, and that the redox state of the mitoNEET [2Fe-2S] clusters is
directly controlled by the reduced flavin and flavin nucleotides.
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Unlike the reduced flavin nucleotides, NADH or NADPH fails to reduce the mitoNEET
[2Fe-2S] clusters under aerobic or anaerobic conditions [22, 23, 30]. However, we find that
NADH can provide electrons to reduce flavin nucleotides via flavin reductase (Figure 1).
When NADH is exhausted, the reduced mitoNEET [2Fe-2S] clusters are quickly oxidized by
oxygen under aerobic conditions (Figure 2). Thus, the redox state of the mitoNEET [2Fe-2S]
clusters may be ultimately controlled by intracellular NADH. In human cells, high glycolytic
activity will lead to accumulation of NADH [28]. Excess NADH may be used by flavin
reductase [43] to reduce flavin nucleotides which in turn reduce the mitoNEET [2Fe-2S]
clusters on mitochondrial outer membrane. As the redox transition of the [2Fe-2S] clusters
in mitoNEET is expected to modulate energy metabolism, iron homeostasis and production
of reactive oxygen species in mitochondria [13], mitoNEET may act as a crucial link
between the redox state of intracellular co-enzymes and mitochondrial functions.
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The salient finding of this work is the specific interaction between FMN and mitoNEET. The
observation that a catalytic amount of flavin nucleotides is sufficient to reduce the
mitoNEET [2Fe-2S] clusters (Figure 4) led us to postulate that the reduced flavin
nucleotides may have a specific interaction with mitoNEET in order to rapidly reduce the
oxidized [2Fe-2S] clusters in mitoNEET. The EPR measurements show that incubation with
the reduced FMN, but not the reduced FAD, indeed produces a new EPR signal at g = 1.85
of the reduced mitoNEET [2Fe-2S] clusters (Figure 5). However, excess amounts of the
reduced FMN are required to produce the EPR signal at g = 1.85 of the reduced mitoNEET
[2Fe-2S] clusters, indicating that binding of the reduced FMN for mitoNEET is not very
strong. It could be that both FMA and the [2Fe-2S] clusters in mitoNEET are reduced.
However, attempts to isolate the mitoNEET-FMN complex under various redox states were
not successful. Thus, FMN binding in mitoNEET could be transient, similar to that in flavin
reductase [38]. We postulate that FMNH2 may rapidly reduce the oxidized [2Fe-2S] clusters
in mitoNEET. Upon oxidation, FMN will have much lower binding affinity for mitoNEET
and dissociate from mitoNEET. Nevertheless, at high concentrations of FMN, the new EPR
signal at g = 1.85 (Figure 5) clearly suggests that mitoNEET has a specific interaction with
FMN.
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Based on the molecular docking models (Figure 6), FMN most likely binds mitoNEET at the
region between the transmembrane α-helix and the [2Fe-2S] cluster binding domain. The
shortest distance between the isoalloxazine group of FMN and the [2Fe-2S] cluster in
mitoNEET is about 10 Å (Figure 6A). Such an arrangement would allow rapid electron
transfer from the reduced FMN to the oxidized [2Fe-2S] cluster in mitoNEET [44]. As
reduction of the [2Fe-2S] cluster in mitoNEET is a single-electron event, reduced flavin
nucleotide must form a semiquinone intermediate after delivering one electron to the
[2Fe-2S] cluster in mitoNEET. However, we were unable to detect any semiquinone signals
using EPR (data not shown). A simplest explanation could be that semiquinone
intermediates may quickly reduce the other [2Fe-2S] cluster in the mitoNEET dimer (Figure
6A). Evidently, additional experiments are required to illustrate the mechanism by which the
mitoNEET [2Fe-2S] clusters are reduced by the reduced flavin nucleotides.

Author Manuscript
Author Manuscript

Using molecular docking approaches, Geldenhuys et al. previously identified two major
binding sites in mitoNEET for type II diabetes drugs rosiglitazone and pioglitazone [45].
Site 1 consists of Lys-42 and Ala-43 from chain 1 and Met-44, Leu-47, Arg-76, His-90, and
Thr-94 from chain 2, while site 2 consists of His-48, Ile-49, Trp-75, Arg-76, Ser-77, and
Lys-78 from chain 1 [45]. The FMN binding site in mitoNEET shown in Figure 6A is
distinct from site 1 and site 2 for type II diabetes drugs rosiglitazone and pioglitazone [45],
but has some significant overlap with site 1. Because of the high insolubility of pioglitazone,
the dissociation constant of the interaction between mitoNEET and pioglitazone was not
determined (36). A more soluble pioglitazone analog, NL-1, has been shown to bind
mitoNEET with a dissociation consistent of 7.4 µM (6). It is expected that pioglitazone or
NL-1 will compete with flavin nucleotides for binding in mitoNEET. In previous studies, we
reported that pioglitazone inhibits the reduction of the mitoNEET [2Fe-2S] clusters
mediated by biological thiols [22] or by human glutathione reductase [23] under anaerobic
conditions. Here, we have also found that pioglitazone and NL-1 can effectively inhibit the
reduction of the mitoNEET [2Fe-2S] clusters mediated by the reduced flavin nucleotides
under aerobic conditions (Wang & Ding, unpublished data). Further investigations on
competition between pioglitazone or its analogs and flavin nucleotides for binding in
mitoNEET may lead to discovery of new drugs that target mitoNEET to modulate energy
metabolism in mitochondria.
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List of Abbreviations
Em7

redox midpoint potential at pH 7.0

EPR

electron paramagnetic resonance

FMN

flavin mononucleotide

FAD

flavin adenine dinucleotide
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Fre

E. coli flavin reductase

NADH

nicotinamide adenine dinucleotide

NADPH

nicotinamide adenine dinucleotide phosphate
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Highlights
•

A mechanism for redox transition of the mitoNEET [2Fe-2S] clusters is
proposed.

•

Reduced flavin nucleotides can rapidly reduce the mitoNEET [2Fe-2S]
clusters.

•

Flavin mononucleotide appears to have a specific interaction with
mitoNEET.
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Figure 1. Reduction of the mitoNEET [2Fe-2S] clusters by reduced flavin nucleotides

A), UV-visible absorption spectrum of purified E. coli flavin reductase (Fre). Purified Fre
(30 µM) was dissolved in buffer containing 500 mM NaCl and 20 mM Tris (pH 8.0). Insert
is a photograph of the SDS-PAGE gel of purified E. coli Fre. B), reduction of the mitoNEET
[2Fe-2S] clusters by the reduced flavin nucleotides. MitoNEET (containing 10 µM [2Fe-2S]
clusters) (spectrum 1) was incubated with E. coli Fre (1 µM) (spectrum 2), Fre and NADH
(50 µM) (spectrum 3), Fre, NADH and FMN (1 µM) (spectrum 4) in buffer containing 500
mM NaCl and 20 mM Tris (pH 8.0) at room temperature under aerobic conditions. For each
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reaction, the UV-visible absorption spectrum was taken after incubation for 2 min. C), EPR
spectra of the mitoNEET [2Fe-2S] clusters. The samples were the same as in A). The EPR
signal at g = 1.94 indicates the reduced mitoNEET [2Fe-2S] clusters. Data are representative
of three independent experiments.
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Figure 2. Redox transition of the mitoNEET [2Fe-2S] clusters mediated by flavin nucleotides
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A), redox transition of the mitoNEET [2Fe-2S] clusters. MitoNEET (containing 10 µM
[2Fe-2S] clusters) was incubated with FMN (1 µM) and NADH (40 µM) under anaerobic
conditions. Addition of Fre (1 µM) rapidly reduced the mitoNEET [2Fe-2S] clusters. Upon
exposure to air, the reduced mitoNEET [2Fe-2S] clusters were quickly re-oxidized. Addition
of additional NADH (100 µM) to the incubation solution under aerobic conditions rereduced the mitoNEET [2Fe-2S] clusters. The absorption peak at 458 nm indicates the
oxidized [2Fe-2S] clusters of mitoNEET. The peak at 420 nm indicates the reduced [2Fe-2S]
clusters of mitoNEET. B), UV-visible absorption spectra of the reaction solution at different
time points. Spectrum 1, mitoNEET was incubated with FMN (1 µM) and NADH (40 µM).
Spectrum 2, at 15 seconds after addition of Fre (1 µM). Spectrum 3, at 4 min after exposure
to air. Data are representative of three independent experiments.
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Figure 3. Reduction of the mitoNEET [2Fe-2S] clusters in the presence of different
concentrations of FMN

Author Manuscript

MitoNEET (containing 10 µM [2Fe-2S] clusters) was pre-incubated with E. coli Fre (1 µM)
and different concentrations of FMN under aerobic conditions. NADH (50 µM) was then
added to initiate the reaction. UV-Visible absorption spectra were taken every 40 seconds for
280 seconds after addition of Fre. FMN concentration in the reaction solution was: 0 µM
(A), 0.0125 µM (B), 0.025 µM (C), 0.05 µM (D), 0.10 µM (E), and 0.20 µM (F). The
absorption peak at 458 nm indicates the oxidized [2Fe-2S] clusters of mitoNEET. The peak
at 420 nm indicates the reduced [2Fe-2S] clusters of mitoNEET. The results are the
representative of three independent experiments.
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Figure 4. Titration of flavin nucleotides in reduction of the mitoNEET [2Fe-2S] clusters
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A), titration of FMN. MitoNEET (containing 10 µM [2Fe-2S] clusters) was pre-incubated
with E. coli Fre (1 µM) and different concentrations of FMN under aerobic conditions.
NADH (50 µM) was then added to initiate the reaction. After 4 min incubation, amounts of
the reduced mitoNEET [2Fe-2S] clusters were measured from the UV-visible absorption
spectra and plotted as a function of FMN concentrations in the reaction solution. B), titration
of FAD. Same as in A), except FMN is replaced with FAD in the reaction solutions. The
data represent the averages with standard deviation from three independent experiments.
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Figure 5. MitoNEET has a specific interaction with FMN
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A), effect of the reduced co-enzymes on the EPR spectrum of the reduced mitoNEET
[2Fe-2S] clusters. MitoNEET (containing 10 µM [2Fe-2S] clusters) was pre-incubated with
no addition (spectrum 1), NADP+ (spectrum 2), NAD+ (spectrum 3), FMN (spectrum 4), or
FAD (spectrum 5) in buffer containing 500 mM NaCl and 20 mM Tris (pH 8.0) at room
temperature for 30 min. The concentration of redox co-enzymes in each incubation solution
was 100 µM. After incubation, the samples were reduced with freshly prepared sodium
dithionite (4 mM) and immediately frozen in liquid nitrogen. The EPR signal at g = 1.94
represents the reduced mitoNEET [2Fe-2S] clusters. Incubation with FMN produced a new
EPR signal at g = 1.85 of the reduced mitoNEET [2Fe-2S] clusters. B), EPR spectra of the
mitoNEET [2Fe-2S] clusters in the presence of different concentrations of the reduced
FMN. MitoNEET (containing 10 µM [2Fe-2S] clusters) was pre-incubated with increasing
concentrations of FMN at room temperature for 30 min. After pre-incubation, the samples
were reduced with freshly prepared sodium dithionite (4 mM) and immediately frozen in
liquid nitrogen for EPR measurements. Data are representative of three independent
experiments.

Free Radic Biol Med. Author manuscript; available in PMC 2018 January 01.

Landry et al.

Page 19

Author Manuscript
Author Manuscript

Figure 6. Molecular docking models of FMN binding in mitoNEET
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A), docking models of FMN binding in mitoNEET (PDB: 2QH7, Paddock et al. 2007). For
clarity, only one monomer in the mitoNEET dimer was shown with the bound FMN
molecule. B), predicted FMN binding site in mitoNEET. The phosphate group of FMN has
electrostatic interactions with Lys-42 and His-39, while the isoalloxazine group of FMN
forms hydrophobic interactions with Met-44 and Ile-45. Dotted lines represent hydrogen
bonds in the mitoNEET-FMN complex.
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Figure 7. Deletion of the residues between Arg-33 and Ile-45 diminishes the interaction between
mitoNEET and the reduced FMN

Author Manuscript

MitoNEET with deletion of the region between Arg-33 and Ile-45 was prepared using the
site-directed mutagenesis. A), UV-visible absorption spectra of mitoNEET and mitoNEET
mutant with the deletion. Spectrum 1, mitoNEET. Spectrum 2, mitoNEET mutant with the
deletion. Insert is a photograph of the SDS-PAGE gel of mitoNEET and mitoNEET mutant
with the deletion. Lane 1, mitoNEET. Lane 2, mitoNEET mutant with the deletion. B), EPR
spectra of mitoNEET and mitoNEET mutant with the deletion after incubation with or
without FMNH2. Purified proteins (containing 10 µM [2Fe-2S] clusters) were incubated
with FMN (100 µM) for 30 min under aerobic conditions, followed by reduction with
freshly prepared sodium dithionite (4 mM). The samples were then subjected to the EPR
measurements. Spectrum 1, mitoNEET. Spectrum 2, mitoNEET after incubation with
FMNH2. Spectrum 3, mitoNEET mutant. Spectrum 4, mitoNEET mutant with deletion after
incubation with FMNH2. Data are representative of three independent experiments.
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